Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 randomized double-blind active-controlled study of SYH9021 in adults with asthma
CTR20261336Phase 3Active
- Sponsor
- Beijing Kangchuanglian Biopharmaceutical Technology Research Center
- Start
- Apr 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of indacaterol, mometasone in asthma, sponsored by Beijing Kangchuanglian Biopharmaceutical Technology Research Center. Started Apr 2026; status: active.
02
Drugs
indacaterolmometasone
03
Conditions
asthma
Beyond the preview
Go deeper on CTR20261336.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20261336.